Science & ResearchAug 29, 2026
Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI.
The safety of omitting up-front treatment with aspirin during primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear.
The safety of omitting up-front treatment with aspirin during primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear. We conducted a multicenter, open-label, randomized trial in Japan involving…
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.